LncRNA AC100865.1通过miR-7/GDF5通路调节巨细胞粘附和ox-LDL摄入
Yong Ren1, Jiarong Liang2, Baofeng Chen2
1Central Medical Laboratory, Zhengzhou Yihe Hospital, Zhengzhou, PR China.
Cellular signalling
|March 17, 2025
概括
这项研究表明,lncRNA AC100865.1,在心血管疾病 (CVD) 中降低调节,增强巨细胞粘附和氧化LDL吸收. 这表明它有可能成为动脉样硬化的诊断标记物和治疗点.
科学领域:
- 分子生物学分子生物学
- 心血管研究研究心血管研究
- 生物标志物发现发现
背景情况:
- 心血管疾病 (CVD) 是导致死亡的主要原因,动脉样硬化 (AS) 和血栓形成是主要的驱动因素.
- LncRNA AC100865.1是一种新型的长非编码RNA,对AS具有潜在的诊断价值.
- 这项研究研究了lncRNA AC100865.1在AS中的治疗含义.
研究的目的:
- 评估lncRNA AC100865.1在动脉样硬化中的治疗潜力.
- 了解lncRNA AC100865.1在AS中的功能背后的分子机制.
- 探索 lncRNA AC100865.1 作为潜在的心血管疾病治疗点.
主要方法:
- 实时PCR测量患者样本中的lncRNA AC100865.1表达.
- 在RAW264.7细胞中过度表达lncRNA AC100865.1,以评估对细胞粘附和氧化LDL吸收的影响.
- 流细胞测量,露西法酶测定和淘汰救援实验以阐明信号通路.
主要成果:
- 在心血管疾病患者中,lncRNA AC100865.1的表达显著下调.
- 过度表达的lncRNA AC100865.1通过miR-7/GDF5/p38/LFA-1通路增强RAW264.7细胞粘附.
- lncRNA AC100865.1通过上调CD36表达来增加巨细胞氧化的LDL吸收.
结论:
- lncRNA AC100865.1在增强细胞粘附和AS中氧化LDL吸收方面发挥着至关重要的作用.
- 循环中的lncRNA AC100865.1显示为心血管疾病的早期诊断生物标志物具有前途.
- lncRNA AC100865.1代表了治疗动脉样硬化和心血管疾病的潜在新型治疗标.
更多相关视频
06:22Isolation of Viable Adipocytes and Stromal Vascular Fraction from Human Visceral Adipose Tissue Suitable for RNA Analysis and Macrophage Phenotyping
Published on: October 27, 2020
3.6K
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
25.1K
相关概念视频
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
